F080 Cutaneous Lymphoma or Not? Clinicopathologic Challenges and Practical Pearls
DESCRIPTION
This interactive session will present case-based diagnostic challenges including a wide range of cutaneous T- and B-cell lymphomas, from uncommon clinical variants of mycosis fungoides to rarer, more aggressive or life-threatening lymphomas. The goal is to familiarize audience members with clinical, histopathologic and molecular tools for diagnosis of cutaneous lymphomas, focusing on clues to distinguish lymphomas from inflammatory mimics. Implications for clinical management will also be discussed.
LEARNING OBJECTIVES
Recognize uncommon presentations of mycosis fungoides and other cutaneous lymphomas based on clinical and histopathologic findings.
Distinguish between cutaneous lymphoma and inflammatory mimics based on clinical and histopathologic findings, immunohistochemical studies, and molecular tests.
Describe how accurately differentiating between cutaneous lymphomas and inflammatory mimics may impact the approach to clinical management.
SCHEDULE
1:00 PM
Welcome and introduction
Kerri Rieger, MD, PhD, FAAD
1:02 PM
Case presentations
Jennifer Yu Wang, MD, FAAD
1:22 PM
Case presentations
Erica Bo Kyung Wang, MD, FAAD
1:40 PM
Case presentations
Roberto Novoa, MD, FAAD
2:00 PM
Case presentations
Youn H. Kim, MD, FAAD
2:20 PM
Case presentations
Kerri Rieger, MD, PhD, FAAD
2:40 PM
Q&A and panel discussion
DIRECTOR
Kerri Rieger, MD, PhD, FAAD
CO-DIRECTOR
Jennifer Yu Wang, MD, FAAD
SPEAKERS
Youn H. Kim, MD, FAAD
Roberto Novoa, MD, FAAD
Erica Bo Kyung Wang, MD, FAAD
DISCLOSURES
Youn H. Kim, MD, FAAD
Corvus Pharmaceuticals – Investigator(Grants/Research Funding); CRISPR Therapeutics – Investigator(Grants/Research Funding); Dren Bio, Inc – Investigator(Grants/Research Funding), Other(No Compensation Received); Innate Pharma S.A. – Other(No Compensation Received); Innate Pharma, S.A. – Investigator(Grants/Research Funding); Kyowa Hakko Kirin Pharma, Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Takeda Pharmaceuticals USA Inc – Investigator(Grants/Research Funding), Speaker(Honoraria); Trillium Therapeutics, Inc – Investigator(Grants/Research Funding);
Roberto Novoa, MD, FAAD
Enspectra Health – Consultant(Stock Options); Iovance Biotherapeutics – Stockholder Public Company(Stock); L'Oreal USA Inc. – Investigator(Grants/Research Funding); Melanoma Research Alliance – Investigator(Grants/Research Funding); Moderna Therapeutics – Stockholder Public Company(Stock); Sanctum LLC – Advisory Board(Stock); Skin Analytics – Investigator(Grants/Research Funding);
Kerri Rieger, MD, PhD, FAAD
Kyowa Kirin – Advisory Board(Honoraria); Pfizer Inc. – Consultant(Fees);
Erica Bo Kyung Wang, MD, FAAD
No financial relationships exist with ineligible companies.
Jennifer Yu Wang, MD, FAAD
Enspectra Health – Consultant (1099 relationship)(Fees); Kyowa Kirin – Advisory Board(Honoraria);